Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Visco VisionTPE:6782 +2.27%99 EV-to-EBIT is 9.77 as of Aug. 19, 2026, which is 59% below its 10-year median of 24.10. GuruFocus rates TPE:6782 with a GF Score™ of 99/100 and a GF Value™ of NT$249.84 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 472 Medical Devices & Instruments companies, Visco Vision ranks better than 76.06% on this metric.
The historical rank and industry rank for Visco Vision's EV-to-EBIT or its related term are showing as below:
TPE:6782'
s EV-to-EBIT Range Over the Past 10 Years
Min: 8.84 Med: 24.1 Max: 69.11
Current: 9.77
During the past 9 years, the highest EV-to-EBIT of Visco Vision was 69.11. The lowest was 8.84. And the median was 24.10.
TPE:6782's EV-to-EBIT is ranked better than 76.06% of 472
companies
in the Medical Devices & Instruments industry
Industry Median: 19.185
vs TPE:6782: 9.77
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Visco Vision's Enterprise Value for the quarter that ended in Jun. 2026 was NT$12,400 Mil.
Visco Vision's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,315 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Visco Vision EV-to-EBIT Related Terms
Visco Vision EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Visco Vision's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6782 vs ISRG, BDX, MDLN: EV-to-EBIT Comparison
For the Medical Instruments & Supplies subindustry, Visco Vision's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Visco Vision EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Visco Vision's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Visco Vision's EV-to-EBIT falls into.
Visco Vision's current Enterprise Value is NT$12,841 Mil.
Visco Vision's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,315 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Visco Vision (TPE:6782) has a EV-to-EBIT of 9.77 as of Aug. 19, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Visco Vision and its competitors. This is 59% below median its historical median of 24.10. Over the past decade, Visco Vision's EV-to-EBIT has ranged from 8.84 to 69.11. According to the industry distribution chart, Visco Vision ranks #113 out of 472 companies in the Medical Devices & Instruments industry, placing it in the top 23.9%.
Is Visco Vision's EV-to-EBIT too high?
Visco Vision's current EV-to-EBIT of 9.77 is 59% below median its 10-year median of 24.10. Over the past 10 years, this metric has ranged from a low of 8.84 to a high of 69.11. The Medical Devices & Instruments industry median EV-to-EBIT is 19.19. Visco Vision's value of 9.77 is 49.1% below this industry median. Based on the distribution chart, Visco Vision ranks #113 out of 472 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Visco Vision has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Visco Vision's EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Visco Vision ranks #113 out of 472 companies for EV-to-EBIT. This places Visco Vision in the top 24% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 19.19. Visco Vision's value of 9.77 is 49.1% below this benchmark. Historically, Visco Vision's own EV-to-EBIT has ranged from 8.84 to 69.11 over the past decade. While the company's 10-year median is 24.10 vs. the industry median of 19.19, Visco Vision has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 19.19, based on 472 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Visco Vision's current EV-to-EBIT of 9.77 is 49.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Visco Vision and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 19.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Visco Vision's current EV-to-EBIT is 9.77, which is 59% below median its own 10-year median of 24.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Visco Vision stock overvalued right now?
Based on GuruFocus' analysis, Visco Vision (TPE:6782) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$249.84, compared to a current price of NT$203.00 — trading 18.7% below its estimated fair value. The current EV-to-EBIT is 9.77, which is 59% below median its 10-year median of 24.10 and 49.1% below the Medical Devices & Instruments industry median of 19.19. Visco Vision's overall GF Score™ is 99/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Visco Vision (TPE:6782), the current EV-to-EBIT is 9.77 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Visco Vision (TPE:6782) Overvalued in 2026?
Based on GuruFocus' analysis, Visco Vision stock appears to be undervalued.
The current stock price of NT$203.00 is trading 18.7% below its estimated GF Value™ of NT$249.84.
GuruFocus considers Visco Vision to be Modestly Undervalued.
Key valuation signals for TPE:6782:
EV-to-EBIT: 9.77 (59% below median its 10-year median of 24.10)
GF Value™: NT$249.84 vs. price of NT$203.00 (18.7% below fair value)
Industry Position: 49.1% below the Medical Devices & Instruments median (#113 of 472)
No single metric tells the full story. See the TPE:6782 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Visco Vision Inc is a manufacturer and seller of disposable contact lenses. The company manufactures Spherical Lenses, Multifocal lenses, Toric lenses, and Cosmetic lenses. Geographically, the company earns maximum revenue from Asia, followed by Europe, Taiwan, and the Americas.
99GF Score
Get the complete analysis for TPE:6782
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6782 has been successfully added to your 
